Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...

Illumina, Inc. (NASDAQ: ILMN), and Ovation.io, Inc., an organization dedicated to building best-in-class multiomics datasets, today announced the development of the largest commercially available ...

Researchers have identified GLP-1 receptor agonists, a class of drugs currently used to treat type-2 diabetes and obesity, as ...

Mum-of-three Mary lost a substantial amount of weight on Mounjaro - but noticed one significant symptom return as soon as she ...

Worldwide’s Alessandra Vignola and Natalia Castro will share emerging study trends and strategies at the GLP-1-Based ...

Ten years later, he built on that research by demonstrating how this naturally occurring peptide could also suppress appetite ...

Lexaria's experience with other GLP-1 drugs to date in humans ... competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the ...

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...